President Donald Trump’s administration withdrew Food and Drug Administration (FDA) nominee Heidi Overton on Tuesday, hours before senators were due to vote on a regulator whose decisions affect U.S. medicines, vaccines and food.
The Senate Health, Education, Labor and Pensions (HELP) Committee’s Nov. 11 notice had placed Overton on the agenda for a 9:45 a.m. ET vote Wednesday, Nov. 18. The Associated Press and CBS News reported the withdrawal on Nov. 17. When checked Nov. 18, the Senate nomination database still listed Overton’s Sept. 24 hearing as its latest recorded action, with no withdrawal entry. No committee vote count was public.
Reuters reported that concerns about Overton’s support among lawmakers preceded the withdrawal.
Senate HELP Committee Chairman Bill Cassidy disputed the view that Overton lacked a path to confirmation. In a post on X, he said he believed she had enough votes to advance through the committee and the full Senate, adding, “Tonight, the White House abandoned a viable confirmation path for Dr. Overton.” Cassidy also said anti-abortion senators had sought final assurances from the administration on “life issues.”
At Overton’s confirmation hearing, Cassidy challenged her role in the administration’s vaccine policy. An Aug. 10 executive order gave the Department of Health and Human Services 90 days to present the president with plans for offering core childhood vaccines individually, starting with measles, mumps and rubella, while keeping combination vaccines available. Cassidy said at the hearing, “The order is based on zero scientific evidence.”
CBS News also reported that questions about Overton’s mifepristone testimony and her implementation of Trump’s pro-vaping policies contributed to difficulties with her nomination. The FDA’s regulatory authority spans food, drugs, biologics and medical devices, according to the agency.
Reuters, citing two people familiar with the matter, reported that Sen. Roger Marshall was being considered as a possible replacement. The committee notice had scheduled its vote for 9:45 a.m. ET Wednesday.


